title: Lipoprotein(a) in alcohol-dependent male patients during a six-month abstinence period.
abstract: OBJECTIVE
  The best known and probably most important mechanism of health-protective moderate alcohol drinking is beneficial changes in plasma lipid levels. We determined changes in main plasma lipid levels in alcohol-dependent patients over a 6-month abstinence period.
  
  
  METHODS
  Fifty-four alcohol-dependent male patients, who were abstinent for less than 14 days, and 20 non-alcoholic males, who had not drunk alcohol for the last month, were studied. In all patients at the study start and after 4 weeks and 6 months observation, lipoprotein(a) [Lp(a)], total cholesterol (TC), HDL cholesterol (HDL), LDL cholesterol (LDL) and triglyceride concentrations, both fasting and 5 h after a fatty meal, were determined.
  
  
  RESULTS
  Alcohol-dependent patients had similar mean fasting and post-prandial plasma lipid levels as the control group, both at the study start and after 4 weeks of abstinence. Whereas, in alcohol-dependent patients after 4 weeks of abstinence, a significant decrease in Lp(a) and fasting HDL levels, as well as a significant increase in fasting LDL level and pro-atherogenic indices of plasma lipids [TC/HDL, (TC-HDL)/HDL, LDL/HDL, Lp(a)/HDL] were observed. Post-prandial levels of studied plasma lipids, except HDL, did not change over the 6-month observation period. In patients who did not remain abstinent for the whole observation period (n = 9), in comparison to abstinent patients, significantly higher HDL levels and a tendency to higher values of LDL, LDL/HDL, Lp(a) and Lp(a)/HDL were found.
  
  
  CONCLUSIONS
  (1) Higher Lp(a) levels soon after alcohol withdrawal may be a factor potentially responsible for the increase of acute cardiac syndromes prevalent in the drinking and early abstinence period, in spite of high HDL concentration; (2) in alcohol-dependent male patients, after a 6-month abstinence period, pro-atherogenic plasma cholesterol fraction changes occurred, expressed by a decrease in HDL level and an increase in LDL concentration.
authors.affiliation: Department of Gastroenterology, Vascular Diseases and Internal Medicine, The Ludwik Rydygier Medical University in Bydgoszcz, Poland.
authors.forename: Jacek
authors.initials: J
authors.lastname: Budzyński
authors.forename: Maria
authors.initials: M
authors.lastname: Kłopocka
authors.forename: Maciej
authors.initials: M
authors.lastname: Swiatkowski
authors.forename: Grzegorz
authors.initials: G
authors.lastname: Pulkowski
authors.forename: Marcin
authors.initials: M
authors.lastname: Ziółkowski
mesh_terms: D000328:Adult; D000437:Alcoholism / Q000097:blood*; D000704:Analysis of Variance; D016022:Case-Control Studies; D002784:Cholesterol / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D005215:Fasting; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D008297:Male; D019518:Postprandial Period; D013695:Temperance; D014280:Triglycerides / Q000097:blood
chemical_list: D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D017270:Lipoprotein(a); D014280:Triglycerides; D002784:Cholesterol